Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
47 |
| 01/09/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
92 |
| 10/13/22 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
|
47 |
| 10/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
87 |
| 04/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
102 |
| 01/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
95 |
| 10/12/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
57 |
| 04/14/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
80 |
| 01/08/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
70 |
| 10/09/20 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
81 |
